| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.081 | 0.08 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.082 | 0.09 |